• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

毛果芸香碱凝胶减轻周期性近视

Reduced cyclic myopia with pilocarpine gel.

作者信息

Mandell A I, Bruce L A, Khalifa M A

机构信息

Mid-South Glaucoma and Cataract Foundation, Memphis, Tennessee 38119.

出版信息

Ann Ophthalmol. 1988 Apr;20(4):133-5.

PMID:3377382
Abstract

Pilocarpine 4% gel and pilocarpine 4% solution were compared in young normal subjects for their effects on induced myopia. The pilocarpine 4% solution produced marked myopia lasting one to two hours which indicates that a qid therapeutic regimen produces about three to six hours of blurred vision during waking hours. The gel-induced myopic effects returned to normal in most subjects nine hours after a single instillation. Thus, pilocarpine-gel-induced myopic effects occur principally while asleep and are reduced substantially upon awakening. This allows patients to carry on normal activities throughout the day.

摘要

在年轻正常受试者中比较了4%毛果芸香碱凝胶和4%毛果芸香碱溶液对诱导性近视的影响。4%毛果芸香碱溶液可产生明显的近视,持续1至2小时,这表明每日四次的治疗方案在清醒时间会导致约3至6小时的视力模糊。在大多数受试者中,单次滴注凝胶后9小时,其引起的近视效应恢复正常。因此,毛果芸香碱凝胶引起的近视效应主要在睡眠时出现,醒来时会大幅减轻。这使得患者能够在一整天内进行正常活动。

相似文献

1
Reduced cyclic myopia with pilocarpine gel.毛果芸香碱凝胶减轻周期性近视
Ann Ophthalmol. 1988 Apr;20(4):133-5.
2
[A myopia study of glaucoma patients following pilocarpine instillation].
Oftalmologia. 2000;52(3):44-8.
3
[A clinical observation of the therapeutic effects of pilocarpine gel for treatment of glaucoma].毛果芸香碱凝胶治疗青光眼疗效的临床观察
Zhonghua Yan Ke Za Zhi. 1998 May;34(3):174-7.
4
[Effect on pressure after instillation of a drop of depot-pilocarpine. Clinical results of its medium-term action].
J Fr Ophtalmol. 1983;6(4):367-74.
5
Management of chronic glaucoma with pilocarpine Ocuserts.
Trans Ophthalmol Soc U K (1962). 1977 Apr;97(1):206-9.
6
[Pilocarpine induced myopia].毛果芸香碱诱发的近视
Klin Monbl Augenheilkd. 1970;156(1):30-9.
7
[One year's experience with pilocarpin-ocusert in the therapy of glaucoma (author's transl)].
Klin Monbl Augenheilkd. 1975 Dec;167(6):870-1.
8
Reversal of tropicamide mydriasis with single instillations of pilocarpine can induce substantial pseudo-myopia in young adults.
Ophthalmic Physiol Opt. 1995 Sep;15(5):475-9.
9
Visual effects of pilocarpine in glaucoma comparative study of administration by eyedrops or by ocular therapeutic systems.毛果芸香碱在青光眼治疗中的视觉效果:滴眼液与眼用治疗系统给药的比较研究
Arch Ophthalmol. 1976 Oct;94(10):1716-9. doi: 10.1001/archopht.1976.03910040490004.
10
Comparative pharmacologic effects of pilocarpine administered to normal subjects by eyedrops or by ocular therapeutic systems.通过滴眼液或眼部治疗系统给予正常受试者毛果芸香碱的比较药理作用。
Am J Ophthalmol. 1975 Oct;80(4):706-12. doi: 10.1016/0002-9394(75)90404-3.

引用本文的文献

1
Topical Application of Bunazosin Hydrochloride Suppresses Myopia Progression With an Increase in Choroidal Blood Perfusion.盐酸比马唑啉滴眼剂通过增加脉络膜血流抑制近视进展。
Invest Ophthalmol Vis Sci. 2023 Nov 1;64(14):15. doi: 10.1167/iovs.64.14.15.
2
Pharmacological Profile and Ocular Hypotensive Effects of Cromakalim Prodrug 1, a Novel ATP-Sensitive Potassium Channel Opener, in Normotensive Dogs and Nonhuman Primates.克罗马林姆前药 1 的药理学特征和降眼压作用,一种新型的三磷酸腺苷敏感性钾通道开放剂,在正常血压的狗和非人灵长类动物中的研究。
J Ocul Pharmacol Ther. 2021 Jun;37(5):251-260. doi: 10.1089/jop.2020.0137. Epub 2021 Mar 30.
3
ATP sensitive potassium channel openers: A new class of ocular hypotensive agents.
ATP敏感性钾通道开放剂:一类新型的降眼压药物。
Exp Eye Res. 2017 May;158:85-93. doi: 10.1016/j.exer.2016.04.020. Epub 2016 Apr 26.
4
Ocular Hypotensive Effects of the ATP-Sensitive Potassium Channel Opener Cromakalim in Human and Murine Experimental Model Systems.ATP敏感性钾通道开放剂克罗卡林在人和小鼠实验模型系统中的降眼压作用
PLoS One. 2015 Nov 4;10(11):e0141783. doi: 10.1371/journal.pone.0141783. eCollection 2015.
5
Efficacy and safety of the combination therapy Pilogel/beta-blocker: interim results.
Doc Ophthalmol. 1989 Aug;72(3-4):391-8. doi: 10.1007/BF00153508.
6
New developments in the drug treatment of glaucoma.青光眼药物治疗的新进展。
Drugs. 1991 Apr;41(4):514-32. doi: 10.2165/00003495-199141040-00002.
7
Long-term treatment with Pilogel/beta-blocker in glaucoma patients.青光眼患者使用 Pilogel/β受体阻滞剂的长期治疗。
Int Ophthalmol. 1991 Jul;15(4):281-4. doi: 10.1007/BF00171032.